Clinicians reported the case of a 61-year-old male diagnosed with alpha-1 antitrypsin deficiency (AATD) who developed an intracranial aneurysm with subarachnoid hemorrhage. The case report will be presented at the 2022 Critical Care Congress, being held virtually April 18-21, 2022 as announced by the Society of Critical Care Medicine.
“Male Caucasian subarachnoid hemorrhage patients with emphysematous changes should be evaluated for AATD as a potential cause of the intracranial aneurysm,” Khizar Hamid, MD, and Paul Berger, DO, said.
The patient experienced headaches and increased blood pressure the day before admission, and was unresponsive on clinical admission. His medical record indicated he suffered from shortness of breath due to his occupation and hypertension, with a recent adjustment of his blood pressure medication. He was intubated for airway protection and went for a detailed clinical examination.
His brain examination showed a massive subarachnoid hemorrhage and a wide-neck aneurysm (2.5 mm deep, 3 mm wide) within the first segment of the left posterior inferior cerebellar artery.
Read more about AATD complications
The aneurysm and bleeding were controlled using a flow diverting stent and an external ventricular drain. In addition, the patient initiated treatment according to the stroke protocol with seizure prophylaxis. When the patient’s clinical condition improved, the external ventricular drain was removed and he was extubated but maintained on oxygen supplementation.
A computed tomographic angiogram of the chest revealed emphysematous alterations with some infiltrates. The clinical team suspected AATD. Therefore, the patient underwent genetic tests and was administered antibiotics. The analysis confirmed a homozygous deficiency.
“AATD has been associated with the development of an intracranial aneurysm, especially in homozygous variants, males and in the Caucasian population,” the authors said. This association has not been established for the Asian population.
The patient’s clinical condition improved and he was discharged to a rehabilitation facility. He recovered without any residual neurological deficits.
Hamid K, Berger P. Subarachnoid hemorrhage associated with homozygous alpha-1 antitrypsin deficiency. Crit Care Med. 2022;50(1):371. doi:10.1097/01.ccm.0000809340.90255.c9